JDFI Gene Therapy Center for Diabetes and Diabetic Complications at UF and UM


Home | Projects | CIT
 

Core E

Investigator: Luca Inverardi

Core E has a two-fold purpose. First, this Core is designed to provide investigators with insulin-producing cells, called islets, that are of the highest quality. Second, Core E will be dedicated to helping investigators with techniques of islet, kidney and aorta transplantation. Both functions are necessary to obtain in vivo proof of principle of the genetic engineering premises of specific Projects.

For the first service, Projects 1, 2, and 4 of this proposal will rely heavily on the Core facility to obtain both islet cells and whole islets that have been obtained from selected animal species. Islets will be used by investigators in Projects 1, 2 and 4 to introduce potentially beneficial molecules through genetic engineering that involves the use of selected viruses. Islet preparations will be rigorously tested for both survivability and function through several techniques that include: staining, analysis of cell-death, islet responsiveness to high glucose, and transplant into diabetic mice. These tests will be used to evaluate the quality of islet preparations, both before and after genetic engineering.

The University of Miami has substantial expertise in the isolation of islets from numerous animal species including mice, rats, pigs, dogs, non-human primates, and humans. This expertise will allow participating project investigators to rapidly progress to highly relevant pre-clinical models as encouraging preliminary results are observed in mice models. Use of this core facility provides numerous investigators with a dedicated facility and training, without the need for useless duplication of resources or the implementation of a time-consuming learning curve. Thus this Core guarantees reliability, reproducibility of the procedures and precise quality control, in a very cost-effective fashion.

The second function is to deliver the highest standards of quality and reproducibility in the transplantation of islets following their re-engineering by investigators in Projects 1, 2, and 4. Similarly, transplants of genetically-manipulated kidney and aorta performed in this facility to Project 3 investigators. Furthermore, Core E will provide training to all investigators to insure standards of excellence in the experiments proposed.

UF Center for Immunology and Transplatation

Questions or comments?

August 16, 2004
Copyright ©1996-2004, University of Florida, College of Medicine
University of Florida Center for Immunology and Transplantation
PO Box 100275, Gainesville, FL 32610-0275
phone: 352 392-0048
fax: 352 392-8464